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Sucralfate enemas present good results in the treatment of colitis, however the mechanism
of  action of the drug is not yet fully clariﬁed.
Objective: To evaluate the anti-inﬂammatory and antioxidant effects of sucralfate enemas
in  diversion colitis model.
Method: Thirty-six Wistar rats underwent intestinal bypass by end colostomy in the
descending colon and distal mucous ﬁstula. The animals were divided into 3 experimen-
tal  groups according to the daily dose of enemas received containing 0.9% SF, sucralfate
enemas or sucralfate enemas 1 g/kg/day or 2 g/kg/day. Each group was divided into two
subgroups according to euthanasia to be performed 2–4 weeks after derivation. The tissue
grade  of inﬂammation was assessed histologically, and neutrophil inﬁltration by the tissue
expression of myeloperoxidase (MPO) identiﬁed by immunohistochemistry and quantiﬁed
by  computerized morphometry. Oxidative stress was measured by tissue levels of malondi-
aldehyde (MDA). To compare the results the Student’s t test variance was used, and also the
variance by ANOVA test, establishing a level of signiﬁcance of 5% (p < 0.05) for both.
Results: The intervention with sucralfate enemas showed improvement in the intensity of
tissue inﬂammation related to the concentration used and the duration of the interven-tion.  Intervention with sucralfate enemas reduced the tissue levels of MPO, independent
of  concentration or time of intervention (p < 0.01). There was a reduction of MDA levels in
animals irrigated with sucralfate enemas, independent of concentration or duration of the
intervention (p < 0.01).
 Study conducted at the Medical Research Laboratory, Graduate Program in Health Sciences, Universidade São Francisco, Braganc¸a
Paulista,  SP, Brazil. Study awarded with the prize Journal of Coloproctology during the 63rd. Brazilian Congress of Coloproctology Congress
(Brasilia (DF), 2014).
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Conclusion: Enemas with sucralfate enemas reduce inﬂammation, neutrophil inﬁltration
and oxidative stress in the excluded colon suggesting topical application of the substance
to  be a valid therapeutic option for the treatment of diversion colitis.
©  2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.
Avaliac¸ão  dos  efeitos  anti-inﬂamatório  e  antioxidante  do  sucralfato  na
colite  de  exclusão
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r  e  s  u  m  e  n
A aplicac¸ão de clisteres com sucralfato (SCF) apresenta bons resultados no tratamento de
colites, entretanto seu mecanismo de ac¸ão ainda não encontra-se esclarecido.
Objetivo: Avaliar os efeitos anti-inﬂamatórios e antioxidantes do SCF em modelo de colite
de  exclusão.
Método: Trinta e seis ratos, foram submetidos a derivac¸ão intestinal por colostomia terminal
no  cólon descendente e ﬁstula mucosa distal. Os animais foram divididos em 3 grupos exper-
imentais segundo receberem clisteres diários com SF 0,9%, SCF 1 g/kg/dia ou SCF 2 g/kg/dia.
Cada  grupo foi dividido em dois subgrupos segundo a eutanásia ser realizada após 2 ou 4
semanas da derivac¸ão. O grau de inﬂamac¸ão tecidual foi avaliado por estudo histológico
e  a inﬁltrac¸ão neutrofílica pela expressão tecidual de mieloperoxidase (MPO) identiﬁcada
por  imunoistoquímica e quantiﬁcada por morfometria computadorizada. O estresse oxida-
tivo  foi mensurado pelo conteúdo de malondialdeído (MDA). Para análise dos resultados
utilizou-se os teste t de Student, e ANOVA, estabelecendo-se para todos os testes nível de
signiﬁcância de 5% (p < 0,05).
Resultados: A intervenc¸ão com SCF melhorou o grau de inﬂamac¸ão tecidual relacionando-
se  a concentrac¸ão utilizada e ao tempo de intervenc¸ão. A intervenc¸ão com SCF reduziu
os  níveis teciduais de MPO, independente da concentrac¸ão ou do tempo de intervenc¸ão
(p  < 0,01). Houve reduc¸ão dos níveis de MDA nos animais irrigados com SCF, independente
da  concentrac¸ão ou tempo de intervenc¸ão (p < 0,01).
Conclusão: Enemas com SCF reduzem o processo inﬂamatório, inﬁltrado neutrofílico e
estresse oxidativo no cólon excluso sugerindo que a substância possa se tornar uma  opc¸ão
terapêutica válida para o tratamento da colite de exclusão.
© 2015 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos los derechos reservados.
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of those various defense systems that form the epithelial pro-ntroduction
ucralfate (SCF) is formed by the association between sucrose
ctosulphate and polyaluminum hydroxide.1 For more  than
hree decades SCF has been used as a cytoprotective agent
or treatment of gastrointestinal ulcer diseases.2 Studies have
hown that the therapeutic effects of SCF appear to be related
o its ability to adhere to erosions and ulcerations in gastroin-
estinal mucosa, forming a difﬁcult-to-remove mechanical
arrier.2 However, it was demonstrated later that SCF also
resents other mechanisms of action.3,4 This drug stimu-
ates the secretion of prostaglandin E2 (PGE2), thus increasing
he production and secretion of mucus by goblet cells of the
astrointestinal epithelium.2 SCF enhances the production of
pidermal growth factor (EGF), which induces cell division and
romotes tissue reepithelialization.3 SCF has antimicrobial
ctivity, acting against the pathogenic bacterial ﬂora present
3n the colonic lumen. It has been shown also that the SCF
olecule has remarkable antioxidant activity, reducing the
roduction and removing oxygen free radicals (OFR) present ininﬂamed tissues.4 This antioxidant action protects the epithe-
lial cells of gastrointestinal mucosa against peroxidation of
phospholipids, the main constituents of cytoplasmic mem-
branes, thus reducing apoptosis.3–5 All of these properties
have led several authors to use SCF for treatment of colorectal
inﬂammatory diseases.2,6–11 The results of these studies con-
ﬁrm that the use of SCF enemas was effective in healing ulcers
of rectal mucosa, as those found, for example, in actinic rec-
titis, ulcerative colitis, solitary ulcer of the rectum and, more
recently, diversion colitis (DC).2,6–11
DC is an inﬂammatory bowel disease (IBD) that has its
onset in colon segments excluded from intestinal transit.12 It
has been shown that epithelial cells of transit-excluded seg-
ments, devoid of their primary energy supply, represented by
short-chain fatty acids (SCFA), undergo changes in their res-
piratory metabolism – increasing, as a result, the formation
of OFR.13,14 The resulting oxidative stress causes breakdowntective barrier.15–17 The rupture of these defense mechanisms
enables the invasion of sterile layers of the intestinal wall
by bacteria from bowel lumen, triggering the inﬂammatory
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response.13,14 In this process, the intense neutrophil migration
further increases OFR production, perpetuating the epithelial
aggression that characterizes DC.13
When one considers that the oxidative stress resulting
from an increased tissue production of OFR by mucous cells
devoid of fecal transit, as well as neutrophil inﬁltration, are
mechanisms involved in DC etiopathogenesis, it will be of
interest to evaluate the antioxidant activity of SCF in an
experimental model of DC. If SCF is able to enhance the inﬂam-
matory process at mucosal level, reduce neutrophil inﬁltration
and diminish OFR production, this drug could become a valu-
able alternative for treatment of DC. The aim of this study
was to evaluate antioxidant and anti-inﬂammatory effects of
a topical application of SCF in an experimental model of DC.
Method
This study followed the recommendations of the Federal Law
11,794 and of the Brazilian College of Animal Experimenta-
tion (COBEA). The research project was approved by the Ethics
Committee on Animal Use in Research (CEUA), Universidade
de São Francisco (Opinion N◦ 22-11/2007).
Experimental  animals
For the present study, 36 male Wistar rats weighing 300–350 g,
provided by the Central Animal Facility, Universidade de São
Francisco, were used. The animals were kept in individual
cages under controlled conditions of temperature, humidity,
light and noise. Prior to the surgical procedure, all animals
were fasted, but with water, for 12 h. The cages were identi-
ﬁed with the number of the rat and the experimental group to
which it belonged. These same data were tattooed on the tail
of each rat.
Surgical  technique
The derivation of the intestinal transit was performed in all
animals under general anesthesia. On the day of surgery, the
animals were weighed to calculate the anesthetic dose. A
1:1 solution containing xylazine 2% (Anasedan, Agribrands
do Brasil Ltda., São Paulo, Brazil) and ketamine hydrochlo-
ride (Dopalen, Agribrands do Brasil Ltda., São Paulo, Brazil.)
in a dose of 0.1 mL/100 g intramuscularly in the left hind paw
was used as anesthetic vehicle. Once anesthetized, the ani-
mals were ﬁxed on the operating table and the entire anterior
abdomen was shaved. Then antisepsis with PVP (povidone
iodine, 10% topical solution) was carried out. The abdominal
cavity was accessed via a 3-cm length midline incision. After
examination of the cavity, the Peyer’s patch, a lymphoid struc-
ture located on the anterior face of the colon, in the transition
between the animal’s rectum and sigmoid colon, was identi-
ﬁed. With the aid of a caliper, the left colon was sectioned at
a standard distance 4 cm above the upper limit of the Peyer’s
patch. The colon’s proximal segment was externalized in the
form of a terminal colostomy on the left ﬂank, and ﬁxed to
the skin with separate points of 4.0 monoﬁlament absorbable
suture applied in four cardinal points and between these
points. After proximal stoma maturation, the caudal segmentFig. 1 – Distribution of experimental groups.
of the sectioned colon was catheterized with a 12F polyethy-
lene tube and subjected to irrigation with 40 mL  of 0.9% saline
solution at 37 ◦C until the whole efﬂuent drained by the ani-
mal’s anus (previously dilated) no longer displayed any fecal
waste output. After this mechanical cleaning, the catheter
was  removed and the distal colon exteriorized through the
abdominal wall as a mucous ﬁstula in the lower left face of
the abdominal wall. The caudal colostomy was ﬁxed to the
skin with the same technique described for the cranial stoma.
After stoma ﬁxation, the abdominal wall was closed in two
surgical plans: peritoneum and aponeurosis with 3–0 braided
polyglycolic acid suture, and the skin with separate points
of 4–0 monoﬁlament nylon. Postoperatively, the animals did
not receive antibiotics, and no further care regarding surgical
incision and the stomata was taken.
Experimental  groups
Fig. 1 shows the distribution of our experimental groups. Our
36 animals were divided randomly into three groups of 12
rats each. In the ﬁrst group, the animals were subjected to an
application of enemas with 0.9% saline warmed to room tem-
perature (control group). The second and the third groups of
animals (experimental groups) received daily applications of
enemas containing SCF (EMS do Brasil Ltda., São Paulo, Brazil)
in two different concentrations (1.0 g/kg/day and 2.0 g/kg/day,
respectively). In all animals the application of intervention
solutions was carried out with the aid of an infusion pump
(KD Scientiﬁc Inc., Holliston, MA, USA) at a controlled infusion
rate of 20 mL/min. In each of the three experimental groups,
six animals were sacriﬁced after two weeks, and the other six
after four weeks.
Sample  collection
In the scheduled dates for euthanasia, animals were anes-
thetized with the same technique described above. The
abdomen was reopened through a midline incision with
greater length. The excluded colon (subjected to the interven-
tion solutions), including the anus of all animals, was carefully
removed. The removed colon segments were opened through
their anti-mesenteric border and rinsed with PBS solution
heated at 37 ◦C for 2 min. A fragment with 3 cm in length
(excluding the anus and the region closest to the stoma) of
each animal was ﬁxed with the mucosa facing up on a piece
of cork. The fragments fastened on cork were stretched with
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he aid of pins. After this fastening procedure, the material
as placed into vials containing 10% buffered formaldehyde
Sigma, St. Louis, MO, USA). During removal of the excluded
olon, a second fragment measuring 1 cm was also removed,
ashed with PBS solution at 37 ◦C, packaged in cryoﬂasks and
tored under ultra-cooling conditions, for further biochemical
nalysis of tissue levels of malondialdehyde (MDA).
istological  analysis
he fragments designated for histological study were kept in
0% formaldehyde for 48 h at room temperature to ensure
roper specimen ﬁxation. Then, the specimens were dehy-
rated by exposure to increasing concentrations of ethanol
nd embedded in parafﬁn. From each block, two 5 m-thick
ragments were cut with the aid of a manual microtome (Leica
M 2235, Leica do Brasil Importac¸ão e Comércio Ltda., São
aulo, Brazil), for slide mounting. One slide was stained by
ematoxylin–eosin (HE) technique and sent for histopatho-
ogical evaluation for the presence of colitis, as well as for the
egree of tissue inﬂammation. The second slide was intended
or immunohistochemistry, to detect the tissue expression
f myeloperoxidase (MPO). All slides were analyzed with
n ordinary optical microscope (Eclipse DS-50, Nikon Inc.,
saka, Japan) by a pathologist specialized in IBD diagnosis and
linded for the origin of the material and the study objectives.
istological photographs were taken using a digital video cam-
ra (DS-Fi-50, Nikon Inc., Osaka, Japan) previously attached
o the microscope body. All specimens analyzed were pho-
ographed with a ﬁnal magniﬁcation of 100×. The reading
f each slide was always done in a histological ﬁeld show-
ng at least three intact and contiguous colonic glands. For
ach slide, three distinct histological ﬁelds were evaluated.
he diagnosis of colitis and the degree of tissue inﬂam-
ation were determined by histological (modiﬁed) criteria
reviously described by Akgun et al.18 (Table 1). The following
Table 1 – Variables used for stratiﬁcation of the
histological degree of tissue inﬂammation.
Findings E score Criterion
Epithelial loss 0  No epithelial loss in mucosa
1 Loss of <5% of epithelial
surface
2 Loss between 5 and 10% of
epithelial surface
3 Loss >10% of epithelial
surface
Crypt
integrity
0 Intact crypts
1 Loss <10% of crypts
2 Loss between 10 and 20% of
crypts
3 Loss >20% of crypts
Inﬂammatory
inﬁltrate
0 Absent
1 Mild
2 Moderate
3 Severe
Modiﬁed from Akgun et al.18 5;3  5(2):90–99 93
stratiﬁcation for histological degree of tissue inﬂammation
was adopted: 0–3, mild; 4–6, moderate; and 7–9, severe.
Immunohistochemistry  for  study  of  tissue  levels  of  MPO
For the immunohistochemical study, all blocks were sectioned
in 5 m-thick sections obtained from colon segments treated
with the intervention solutions. These cuts were deposited in
previously silanized slides and identiﬁed with the number of
the rat and the group to which he belonged. Slides were diaph-
anized and rehydrated, and antigen retrieval was performed
using the Trilogy solution (Cell Mark Inc., Rocklin, CA, USA).
Next, the slides were rinsed with distilled water and subse-
quently immersed in PBS solution for 10 min  and dried with
ﬁlter paper. Endogenous peroxidases were blocked using 3%
hydrogen peroxide (H2O2) in a humid chamber at room tem-
perature for 10 min. Then, further washing was performed
with PBS for 10 min. After this process, the slides were left rest-
ing at room temperature for 10 min  and then washed with PBS
for 5 min. The primary polyclonal anti-MPO antibody (Dako
do Brazil Ltda., São Paulo, Brazil) with cross-reactivity to rats
was diluted in saline containing bovine serum albumin (1%)
diluted 1:100. All slides were coated with 100 L of this solution
and left resting at room temperature for a period of 2 h. Follow-
ing exposure to primary antibody, the slides were rinsed with
distilled water (2 baths) and PBS buffer (two baths of 2 min).
Then, the slides were incubated with an avidin–biotin system
(secondary antibody) comprising the LSAB + kit System-HRP
(Dako do Brasil Ltda., Sao Paulo, Brazil) for a 35-min period of
exposure for each reagent, and then washed with two baths
of PBS. The section processing occurred by using the Liquid
DAB + Substrate Kit (Dako do Brasil Ltda., São Paulo, Brazil) in
a dilution of 1 drop of chromogenous solution in 1 L of buffer
solution. 100 L of the chromogen was added over the sec-
tions for a period of 5 min  at room temperature. After this
processing, the sections were washed in running water and
counterstained with Harris hematoxylin for 30 s. After this
process, the slides were again washed in running water, until
removal of excess dye. Finally, the slides were dehydrated in
three baths with increasing concentrations of alcohol and two
baths of xylene. The slides were then mounted with coverslips
and resin.
Computerized  morphometry
The immunostaining was considered positive when a dif-
fusely brownish color was present, with variable intensity
points and a homogeneous distribution in neutrophils. As
recommended by the manufacturer, the negative control for
the immunostaining was performed without the addition
of primary antibody; and the positive control was  made in
human vermiform appendix suffering from acute appendici-
tis. The presence of a brownish color makes it possible to
quantify its tissue content by computerized morphometry
(computer-assisted image  processing). The MPO  content was
then measured with the aid of NIS-Elements 4.0 software
(Nikon Inc., Osaka, Japan). Like the histological analysis, the
tissue content of MPO  in each sample was always determined
in a site where there were at least three contiguous crypts.
The image  analysis program using color histograms in RGB
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(Red, Green, Blue) system is able to determine the amount of
the selected color (in this case the brown color, that in which
MPO  is expressed) present in the tissue, converting color inten-
sity into number of pixels in each selected ﬁeld. Thus, the
ﬁnal content of MPO  was determined in percentage by ﬁeld
(%/ﬁeld). The ﬁnal amount considered for each rat represented
the average value obtained after reading three histological
ﬁelds in the established magniﬁcation (100×).
Determination  of  malondialdehyde  (MDA)  levels
The levels of lipid peroxidation were evaluated by measuring
the levels of thiobarbituric acid reactive substances (TBARS),
as with MDA,  with a previously described methodology.19 MDA
is a secondary product of lipid oxidation and is considered a
potential candidate for being a general biomarker of oxida-
tive stress. As to the quantiﬁcation of tissue levels of MDA,
1 g of each fragment was placed in 5 mL  of phosphate buffer
and homogenized by vortex and ultrasound sonication for 30 s,
alternately, repeating the process for three times. Then, 250 L
of the supernatant obtained from the homogenization process
was transferred to a plastic test tube containing 25 mL  of 4%
methanolic BHT, with a new vortex homogenization. The sam-
ple was then mixed with 1 mL  of 12% trichloroacetic acid, 1 mL
of 0.73% thiobarbituric acid and 750 L of Tris/HCl buffer, and
then incubated in a water bath at 100 ◦C for 60 min. After this
step, the tubes were immediately placed in a container with
ice to block the reaction, with addition of 1.5 mL  of n-butanol.
Then, the mixture was again vortexed for 30 s. The sam-
ples were separated by centrifugation for 10 min  at 5000 rpm.
Finally, the supernatant was removed, and the absorbance at
532 nm of the organic phase was analyzed, using a UV/vis 6105
(Jenway, Bibby Scientiﬁc Limited, Cheshire, UK) spectropho-
tometer.
Statistical  analysisThe results for the degree of inﬂammation were described
according to the median of the values obtained. As to tissue
Fig. 2 – (A) Mucosa without trafﬁc subjected to intervention with
mucosal surface with formation of erosion, tortuosity of colonic 
transit subjected to intervention with SCF (2.0 g/kg/day) for 4 we
surface, that is preserved, without erosions and with colonic gla0 1 5;3  5(2):90–99
levels of MPO and MDA, the results were described according to
their media ± standard error. The comparison of results found
among experimental groups was analyzed by Student’s t test.
ANOVA test was used to study the variation in results accord-
ing to the intervention time in each experimental group. It was
established for all tests the level of signiﬁcance of 5% (p < 0.05),
and we used one asterisk (*) to identify values of p < 0.05 and
two asterisks (**) for values of p < 0.01.
Results
Fig. 2A shows colonic epithelium excluded from bowel tran-
sit, submitted to intervention with 0.9% saline for 4 weeks,
while Fig. 2B shows the colon without transit submitted to
irrigation with SCF at a concentration of 2.0 g/kg/day.
Fig. 3 shows the degree of tissue inﬂammation, compared
with animals subjected to intervention with 0.9% saline, SCF
1.0 g/kg/day and SCF 2.0 g/kg/day for 2 and 4 weeks.
Fig. 4A shows the tissue expression of MPO  in the segments
without transit and subjected to intervention with 0.9% saline
for 4 weeks, while Fig. 3B shows the colon without transit sub-
jected to irrigation with SCF at a concentration of 2.0 g/kg/day
for 4 weeks.
Fig. 5 shows MPO tissue content by comparing animals sub-
jected to intervention with 0.9% saline, SCF 1.0/kg/day and SCF
2.0/kg/day for 2–4 weeks.
Fig. 6 shows MDA tissue content by comparing animals sub-
jected to intervention with 0.9% saline, SCF 1.0 g/kg/day and
SCF 2.0 g/kg/day for 2 and 4 weeks.
Discussion
The colonic epithelium is considered the most perfect func-
tional barrier of the human body.13 Formed by a single layer of
cells, it separates the colonic lumen, an antigen and bacteria-
16,17rich environment, from the sterile internal environment.
This property becomes important when we  consider that
in the early stages of IBD, especially ulcerative colitis, the
colonic mucosa is consistently impaired, suggesting that the
 0.9% saline for 4 weeks. Apparent irregularity of the
glands (HE – 100×). (B) Colonic mucosa without intestinal
eks. Formation of a protective layer of SCF on the epithelial
nd alignment (HE – 100×).
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isruption of the epithelial barrier is an early event related
o the pathogenesis of the disease.14 The importance of
pithelial barrier integrity is enhanced when one considers
hat the major experimental models proposed for colitis
nduction use chemicals such as trinitrobenzene sulphonic
cid (TNBS), H2O2, acetic acid and dextran sulfate in order
o disrupt the epithelial barrier, thus allowing the bacterial
nvasion and consequently an acute inﬂammatory response
hat characterizes the disease.20
However, the early molecular mechanisms that trigger the
njury of those different defense systems that form the colonic
arrier in patients with IBD have not been fully clariﬁed.14
ne of the possible pathogenic mechanisms involved in the
nitial injury of the colonic mucosal barrier was suggested by
ravda in 2005, that proposed the theory of colitis induction by
FR.14 According to Pravda, the pathogenesis of colitis had two
istinct stages. In the ﬁrst stage, called by the author as “ini-
iation phase”, the initial insult to the intestinal mucosa was
ig. 4 – (A) Intense mucosal MPO  expression, among colonic glan
ubjected to intervention with 0.9% saline solution for 4 weeks (H
n animal submitted to intervention with SCF 2.0 g/kg/day for 4 .9% saline and SCF 1.0 g/kg/day) (p < 0.01). Student’s t test.
a result of the increased production of OFR by  the epithelial
cells of the colon mucosa themselves, with changes in their
energy metabolism. The overproduction of OFR by these cells
would cause breakage of those different defense lines that
make up the mucosal barrier, allowing migration of bacteria
and antigens present in the intestinal lumen into the ster-
ile intimacy of the submucosa.14 In the second stage, called
“spreading phase”, neutrophils would migrate into the intesti-
nal wall in an attempt to combat the bacterial inﬁltration,
disseminating the inﬂammatory process.14,21,22 The possibil-
ity that the increased production of OFR may cause injury to
the colonic mucosal epithelium has been known for several
years, when it was shown that H2O2 (a potent OFR generator)
instillation inside the colon was followed by a severe picture of
colitis, sometimes with a fatal outcome.23–25 It should be noted
that H2O2-induced colitis presents clinical, macroscopic and
microscopic features very similar to those found in ulcerative
colitis.26
ds and inside submucosal blood vessels in an animal
E – 100×). (B) Minor tissue expression in colonic mucosa of
weeks (HE – 100×).
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However, in order to experimentally verify if the colon
mucosa cells with changes in their energy metabolism would
be able to produce OFR in sufﬁcient quantity to damage the
intestinal epithelium, it would be necessary to establish an
experimental model of colitis where the initial damage to
the mucosa was not caused by the exposure of the intesti-
nal epithelium to chemicals, but by conditions that only would
alter the cellular metabolism.13 SCFA, represented by butyrate,
propionate and acetate, account for 90% of all substrate used
by colonic mucosa cells to obtain energy, and the simple depri-
vation of these substances to the mucosa alters the energy
metabolism of colonocytes, leading to the appearance of
DC.2,13,16,17 In the face of this evidence, an experimental model
of DC would assess the ability of epithelial cells excluded from
bowel transit in producing larger amounts of OFR, and also
would verify if the resulting oxidative stress could damage
the different lines of epithelial defense. A number of studies
using an experimental model of DC showed that the colonic
mucosa cells excluded from fecal transit are subjected to
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Fig. 6 – MDA tissue content, comparing animals subjected to inte
2.0 g/kg/day for 2 and 4 weeks. **Signiﬁcant: SCF 2.0 g/kg/day antissue oxidative stress through an increase in the production
of OFR.13 It has also been demonstrated that an overproduc-
tion of OFR causes harm to the colonic mucosa, decreases the
population of goblet cells, reduces the content and modiﬁes
the expression of mucins, causes disruption of protein con-
stituents of intercellular junctions, and also causes oxidative
damage to cellular DNA.13,15–17,27–29 All these ﬁndings con-
ﬁrmed the higher capacity of OFR production by colonic cells
with metabolic changes, as shown by the relationship between
an increased production of OFR and the disruption of different
defense systems of epithelial barrier.13
Based on these ﬁndings, several studies began to test the
effectiveness of substances with antioxidant activity for the
treatment of DC.19,30–32 The results of these studies conﬁrmed
that natural or synthetic substances with antioxidant activity
were able to reduce the production of OFR and to improve the
histological changes that characterize DC.19,29–32
Riley et al. in 198933 were the ﬁrst to demonstrate the ben-
eﬁts of using enemas with SCF in the acute phase of ulcerative
**
**
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d SCF 1.0 g/kg/day × 0.9% saline (p < 0.01). Student’s t test.
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ectitis. Subsequently, other studies have conﬁrmed the efﬁ-
acy of the drug in other forms of colitis.5,6,8–10 Most of these
uthors attributed the action of the drug to its adhesive capac-
ty on the inﬂamed epithelium. Riley et al. in 198933 were the
rst to demonstrate the beneﬁts of using enemas with SCF
n the acute phase of ulcerative proctitis. Subsequently, other
tudies have conﬁrmed the efﬁcacy of the drug in other forms
f colitis.5,6,8–10 Most of these authors attributed the action
f the drug to its adhesive propriety on the inﬂamed epithe-
ium, regardless of its important antioxidant action, already
nown for decades.7,34 The antioxidant activity of SCF was
he result of the drug’s ability to remove the OFR formed in
he tissues under different experimental conditions.35–37 Only
ne study evaluated the effects of the application of ene-
as  with SCF in an experimental model of DC.2 The authors
ound that this substance reduced signiﬁcantly the epithelial
oss, decreased the abscess formation within intestinal crypts,
nd also reduced the inﬂammatory inﬁltrate and local colla-
en deposition,2 in line with other studies that attributed the
mprovement of the mucous inﬂammatory process to the SCF
bility to form a protective layer on the inﬂamed mucosa.2
hile drawing attention to other mechanisms of action of this
rug, these studies did not assess the possibility that the ben-
ﬁcial effects of the substance could be related to a possible
ntioxidant action.2
In this study, we  aimed to verify if the therapeutic action
f SCF could be related to its antioxidant properties. We used
he DC model, because oxidative stress is now considered one
f the molecular mechanisms related to the etiopathogene-
is of this disease.13–17 With the DC model, we could conﬁrm
he results previously described, as we  showed that the use of
nemas with SCF reduced the degree of tissue inﬂammation.2
sing a previously validated inﬂammatory scale, we  found
hat the degree of tissue inﬂammation decreased signiﬁcantly
n animals in which we applied enemas with higher SCF con-
entrations for a longer period. These ﬁndings showed that
he topical effect of SCF depends on the concentration used
nd the intervention time. In all animals which underwent
ntervention with SCF, we  could detect, through the histolog-
cal study, the formation of a thin protective ﬁlm covering the
olon mucosa in most animals. This ﬁnding, coupled with the
mprovement of the degree of tissue inﬂammation, conﬁrms
he ability of this drug, in acting as a mechanical barrier hin-
ering the contact between the epithelium with the existing
ora in the intestinal lumen. However, if the action of this drug
as purely mechanical, by force the tissue inﬂammation score
hould be lower from the ﬁrst weeks of intervention, which
uggests that other mechanisms of action are involved.
The colonic mucosa inﬁltration by inﬂammatory cells is
nother common ﬁnding in DC. In more  severe cases, in
he acute phase the inﬁltrate is composed predominantly
f neutrophils, whereas in the chronic phase, the lympho-
ytes become the main cells, although still with neutrophils
resent in tissues.15 MPO  is an enzyme found primarily in
he azurophilic granules of neutrophils.13 While MPO may be
resent in other inﬂammatory cells, it is estimated that 95% of
ll its content comes from the neutrophils; this ﬁnding makes
his substance an efﬁcient marker for the presence of an acute
nﬂammatory inﬁltrate. Previous studies used tissue dosage of
PO  content in order to conﬁrm the presence of a neutrophil 5;3  5(2):90–99 97
inﬁltrate in DC.13,38 In this study, when we analyze the inﬁltra-
tion of neutrophils for assessing the tissue content of MPO,  we
found that animals subjected to SCF intervention had a lower
content of MPO compared to animals receiving intervention
with 0.9% saline. The reduction in neutrophilic inﬁltrate was
not related to the concentration of SCF used or to the inter-
vention time. There are several possible explanations for this
ﬁnding. Perhaps the formation of a mechanical barrier over the
epithelial surface made it difﬁcult for the occurrence of bowel
wall invasion by bacteria from the colonic lumen, decreasing
the neutrophil inﬂammatory response. Possibly the antimicro-
bial properties of SCF could decrease the number of bacteria in
bowel lumen, thus decreasing the neutrophil inﬁltration. Like-
wise, if SCF can reduce OFR production, the epithelial injury
will be smaller, which would decrease the bacterial inﬁltration.
In turn, the penetration of a lower number would diminish the
inﬁltrate and, thus, the production of OFR from neutrophils,
which would conﬁrm the antioxidant activity of SCF.
To evaluate the antioxidant action of SCF, we  used MDA
tissue content dosage. The products of lipid peroxidation of
phospholipids present in cell membranes, such as MDA,  can
be used as indicators of OFR action in the body.39 By far, MDA
determination is the most popular indicator of oxidative dam-
age to cells and tissues.39 We  noted that in the ﬁrst two  weeks
of intervention with SCF, a signiﬁcant reduction in MDA  tissue
content already had taken place, even when we  applied a lower
concentration of the substance. MDA tissue content remained
low after four weeks of intervention, regardless of SCF con-
centration used. This showed that the substance maintained
its antioxidant activity. On the other hand, in the control
group animals, MDA levels progressively increased with the
passage of time, showing that the longer the epithelial cells
were deprived of their SCFA supply, the higher the level of tis-
sue oxidative stress. These ﬁndings conﬁrm the antioxidant
power of SCF, since the action of this drug is not dependent
on the concentration used or on the intervention time. The
decrease in MDA levels was directly related to the improve-
ment of the neutrophilic inﬁltrate within the ﬁrst weeks of
intervention, remaining that way throughout the intervention
period. The lower MDA content was also directly related to the
improvement of the degree of inﬂammation after four weeks
of intervention. This ﬁnding shows that SCF reduces oxidative
stress in tissue and preserves the epithelial barrier, resulting
in a smaller acute inﬂammatory response.
The results of this study conﬁrm that SCF has antioxidant
action, as previously shown.5 When one considers that DC
pathogenesis is related to oxidative stress, the results suggest
that the application of enemas with SCF is a new and effective
therapeutic approach for the treatment of this disease. Its low
cost, easy availability and the lack of serious side effects are
additional advantages to be considered, to minimize the suf-
fering of patients with DC already living with the limitations
imposed by the presence of a stoma.
ConclusionUnder the conditions of this experimental study, we  conclude
that the application of enemas containing SCF in a colon with
transit exclusion reduces the levels of tissue oxidative stress,
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decreases neutrophil inﬁltration and improves tissue inﬂam-
mation, conﬁrming the antioxidant action of this substance.
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